Category Archives: Dr. Jim Turpin

  1. Beyond 2010: Gaps, Challenges and Priorities for the Future of PrEP

    From AIDS Research and Human Retroviruses, by Veronese, Turpin and Feuer A workshop entitled Beyond 2010: Gaps, Challenges, and Priorities for the Future of Preclinical HIV Pre-Exposure Prophylaxis (PrEP) was sponsored by the Division of AIDS (DAIDS) of the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), on October 20-21, 2009, in Read More >>

    Dr. Jim Turpin, NIH, PrEP, research
  2. Join IRMA in learning the basic science of drug discovery

    via IRMA Enhance your advocacy skills and bone up on some of the basics. Dr. Jim Turpin of the Microbicide Research Branch at the National Institutes of Health, National Institutes of Allergy and Infectious Diseases, will explain the basic science of drug discovery – the research that happens before we move on to Phase I safety testing Read More >>

    Dr. Jim Turpin, IRMA, NIH, teleconference
  3. The Future of Rectal Microbicides – an IRMA Q&A with Dr. Jim Turpin

    Each step is part of the waft and weave leading to a safe, acceptable and effective rectal microbicide. IRMA asks Jim Turpin, Ph.D., Microbicide Research Branch*, about the National Institutes of Health and its commitment to rectal microbicides IRMA: Why are rectal microbicides an important part of the NIAID/NIH prevention portfolio? Dr. Turpin: Rectal microbicides are important Read More >>

    behavioral research, CDC, DAIDS, Dr. Jim Turpin, men, MSM, new prevention technologies, NIAID, NIH, PrEP, research, women